Correlation Between Viridian Therapeutics and Design Therapeutics
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Design Therapeutics, you can compare the effects of market volatilities on Viridian Therapeutics and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Design Therapeutics.
Diversification Opportunities for Viridian Therapeutics and Design Therapeutics
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Viridian and Design is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Design Therapeutics go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Design Therapeutics
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 0.55 times more return on investment than Design Therapeutics. However, Viridian Therapeutics is 1.81 times less risky than Design Therapeutics. It trades about -0.11 of its potential returns per unit of risk. Design Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 1,967 in Viridian Therapeutics on October 23, 2024 and sell it today you would lose (154.00) from holding Viridian Therapeutics or give up 7.83% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Design Therapeutics
Performance |
| Timeline |
| Viridian Therapeutics |
| Design Therapeutics |
Viridian Therapeutics and Design Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Design Therapeutics
The main advantage of trading using opposite Viridian Therapeutics and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |